|
|
Cancer survivor preparing for transplant (Wetaskiwin Times Advertiser) |
 |
 |
|
It has been tough journey for Rose Ganley, but the little girl with the bright smile still has a long way to go. In October 2006, when she was just two-years-old, the Wetaskiwin toddler was diagnosed with leukemia and a rare form of Down syndrome. read more |
|
|
DOR BioPharma Has SPA Clearance From FDA To Start Confirmatory Phase 3 Clinical Trial Of OrBec(R) In GI GVHD (Medical News Today) |
|
|
|
DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB) announced that it has reached agreement with the US Food and Drug Administration (FDA) on the design of a confirmatory, pivotal Phase 3 clinical trial evaluating its lead product orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI GVHD). read more |
|
Santa Cruz doctor helps save lives of family who ate poisonous ... - San Jose Mercury News |
|
|
|
None of the patients underwent transplants. All recovered but one, the 83-year-old grandmother. Her liver recovered but she succumbed to kidney failure. ... read more |
|
|
Older Women Less Likely Than Men to Be Listed for Kidney Transplants - AScribe (press release) |
|
|
|
7 in the Journal of the America Society of Nephrology, Segev and his team looked at data from the United States Renal Data System (USRDS) kidney transplant ... read more |
|
EyeGate Pharma Receives Orphan Drug Designation For Corneal Graft Rejection From U.S. FDA (Medical News Today) |
|
|
|
EyeGate Pharma, the leader in ocular drug delivery, and a specialty pharmaceutical company using iontophoresis technology to safely and non-invasively deliver therapeutics to treat serious ocular diseases, announced that the U.S. read more |
|
|
|
|
<< Start < Prev 181 182 183 184 185 186 187 188 189 190 Next > End >>
|
|
Page 183 of 322 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
